Complement Therapeutics Alternatives & Competitors
12 companies similar to Complement Therapeutics — Developing the next generation of complement medicines
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine lea...
Cambridge, United States
Deciduous Therapeutics
Deciduous is developing a novel class of immune-modulatory therapies designed to promote a...
San Francisco, United Sta...
Life Biosciences
Targeting the biology of aging
Boston, United States
YouthBio Therapeutics Inc.
Developing partial reprogramming gene therapies for Alzheimer’s and other diseases of agin...
Seattle, United States
Track all Complement Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
NodThera
Treating chronic disease by targeting inflammation at its source
Philadelphia, United Stat...
Attralus
Attralus is a biopharmaceutical company creating transformative medicines for patients wit...
Naples, United States
Tune Therapeutics
Mastering the epigenome, unlocking complex disease.
Seattle, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Perceive Biotherapeutics, Inc.
South San Francisco, Unit...
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
Agoura Hills, United Stat...
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
Menlo Park, United States
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
About Complement Therapeutics
Developing the next generation of complement medicines
Research and development of complement-related disease therapies, Development of gene and protein-based therapeutic platforms, Mass spectrometry for complement protein measurement
Patients with complement-mediated diseases, Individuals with age-related macular degeneration, Healthcare providers specializing in ocular and systemic diseases
Complement-Mediated Diseases, Gene Therapy, Geographic Atrophy, Dry Age-Related Macular Degeneration, Precision Medicine, Diagnostic Platform, Vision Loss, Retinal Diseases, Complement Cascade, Preclinical Research, Patient Stratification, Efficacy Biomarker, Therapeutic Development
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Complement Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Complement Therapeutics on 28 Jan 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.